NCT03751098View on ClinicalTrials.gov

Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation

PHASE3CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

January 21, 2019

Study Completion Date

January 21, 2019

Conditions
Mydriasis
Interventions
DRUG

Tropicamide/Phenylephrine ophthalmic solution (TR/PE)

Tropicamide 1%/phenylephrine 2.5% ophthalmic solution administered with the Optejet microdose dispenser

DRUG

Placebo

Eyewash administered with the Optejet microdose dispenser

Trial Locations (2)

78229

R&R Research, San Antonio

78731

Keystone Research, Austin

Sponsors

Lead Sponsor

Eyenovia Inc.
All Listed Sponsors
lead

Eyenovia Inc.

INDUSTRY